Colli-Pee recognized at the prestigious Henry Van de Velde Awards

 

Novosanis and Voxdale have been awarded the prestigious Henry Van de Velde Award in Design for Healthcare.

Colli-Pee™, Novosanis’ innovative urine sampling device has won the Henry van de Velde Award the largest design awards in Belgium. The product is a result of the strong collaboration between two Belgian organizations, Novosanis, a MedTech company and Voxdale, a Design and Engineering Agency. Also, governmental support from VLAIO has been vital in the design and development trajectory.

 

An international jury and over 1400 design professionals selected the winner based on various criteria. Products were awarded for best design in 10 different categories including Healthcare, Communication, and Everyday Life. Novosanis is proud to have been recognized with the award in Healthcare and become part of Belgium’s rich design history.

 

“Colli-Pee enables in a super user-friendly way the standardized collection of first-void urine by both men and women. First-void urine is highly concentrated, allowing improved detection of several biomarkers. This opens new opportunities in the medical world to detect infectious diseases and early stage cancers in a non-invasive way. All relevant to create a patient and user-centric and sustainable health care system.” says Vanessa Vankerckhoven, CEO of Novosanis.

 

“The smart and unique mechanical design of the product permits initial urine to be captured and creates a passage for superfluous fluid to directly pass into the toilet, without disrupting flow. This was the key challenge in standardizing the sample which of course is very important to create an accurate test. Voxdale is very pleased with its contribution in the success story of Colli-Pee and the recognition of our design and simulation skills in MedTech and Healthcare in general.” stated Koen Beyers, CEO of Voxdale.

Note

About Novosanis

Novosanis is an innovative developer and producer of medical devices adding value to the accuracy of diagnostics tests as well as drug delivery in the field of prevention, detection and treatment of infectious diseases and oncology.

 

Novosanis is a Belgian privately held company endorsed on multiple occasions nationally and internationally for its solutions and is ISO13485 certified.

 

Novosanis prospers in user-friendly and clever medical devices meeting all regulatory and quality requirements for self-sampling and drug delivery solutions that improve accuracy and standardization while making handling easier, more consistent and more comfortable for the user.

 

The company has two device platforms in portfolio:

 

  • VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery of e.g. therapeutic, prophylactic and allergy vaccines in the dermal layer of the skin and
  • Colli-Pee™ is a patented sampling device suited for standardized and guaranteed collection of first-void urine (first 20ml of the urine flow) allowing improved detection of infectious diseases as well as early stage cancer. Colli-Pee™ is in a commercial stage. It is CE-marked and FDA listed.
    For more information, please visit: www.novosanis.com

 

About Voxdale

Voxdale is a design, engineering and research agency for mechanical and mechatronical development of devices, systems and equipment, for clients in MedTech, space & aerospace, performance sports, and in industrial sectors.

 

The design and engineering team, consisting of seasoned experts, is continuously involved in the field of engineering, device architecture, product development and technology integration, tackling challenges of thermal management, flow analysis and materials selection.

 

The aim is to provide the necessary expertise and skills to guide clients through projects from the idea phase, up to building prototypes, supported with all regulatory insights, and followed by manufacturing and production.
By using simulations, including state-of-the-art finite element analysis (FEA) and computational fluid dynamics (CFD), Voxdale is able to minimize the development path and all risks involved, as well as optimizing existing designs and systems.

 

Voxdale is involved in projects with Novosanis, Biocartis, eSaturnus, AmatsiSeps, etc.
For more information, please visit: www.voxdale.be

 

 

Interested in a regular update of the Life Sciences and biotech sector in Flanders?